Published in Genome Res on February 23, 2016
Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits. Epigenetics Chromatin (2016) 0.79
Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations. Cancer Discov (2016) 0.75
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities. Clin Epigenetics (2017) 0.75
Potential energy landscapes identify the information-theoretic nature of the epigenome. Nat Genet (2017) 0.75
Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature (2009) 24.41
Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet (2012) 15.21
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem (2008) 10.08
Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell (2013) 9.55
Software for computing and annotating genomic ranges. PLoS Comput Biol (2013) 8.20
ChromHMM: automating chromatin-state discovery and characterization. Nat Methods (2012) 7.66
Super-enhancers in the control of cell identity and disease. Cell (2013) 7.50
Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet (2010) 7.39
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol (2010) 6.67
An atlas of active enhancers across human cell types and tissues. Nature (2014) 6.57
Cancer invasion and the microenvironment: plasticity and reciprocity. Cell (2011) 6.36
ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res (2012) 6.29
Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer (2013) 6.13
Charting a dynamic DNA methylation landscape of the human genome. Nature (2013) 5.80
Tumour heterogeneity and cancer cell plasticity. Nature (2013) 5.47
Functional and mechanistic diversity of distal transcription enhancers. Cell (2011) 5.22
Evaluation of the Infinium Methylation 450K technology. Epigenomics (2011) 4.90
The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med (2013) 3.96
Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell (2012) 3.65
To differentiate or not--routes towards metastasis. Nat Rev Cancer (2012) 3.59
Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet (2007) 3.12
DNA methylation dynamics in health and disease. Nat Struct Mol Biol (2013) 2.58
Impact of aging on DNA methylation. Ageing Res Rev (2003) 2.50
Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat Genet (2013) 2.41
Activating c-kit gene mutations in human germ cell tumors. Am J Pathol (1999) 2.15
Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol Cell (2014) 1.99
Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Hum Mol Genet (2013) 1.95
Enhancer RNAs and regulated transcriptional programs. Trends Biochem Sci (2014) 1.85
DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes. Genome Biol (2013) 1.71
KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene (2005) 1.64
Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer. Genome Res (2014) 1.63
DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci (2009) 1.62
Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells. Cancer Res (2004) 1.53
Enhancers as information integration hubs in development: lessons from genomics. Trends Genet (2012) 1.52
DISEASES: text mining and data integration of disease-gene associations. Methods (2014) 1.33
Overexpression of FMNL2 is closely related to metastasis of colorectal cancer. Int J Colorectal Dis (2008) 1.28
Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer. Cell Rep (2014) 1.27
Global view of enhancer-promoter interactome in human cells. Proc Natl Acad Sci U S A (2014) 1.26
Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer. Breast Cancer Res (2008) 1.24
Cancer: pathological nuclear reprogramming? Nat Rev Cancer (2014) 1.17
Genome-wide analysis of DNA methylation and the gene expression change in lung cancer. J Thorac Oncol (2012) 1.16
DNA methylation of transcriptional enhancers and cancer predisposition. Cell (2013) 1.12
5-Methylcytosine DNA demethylation: more than losing a methyl group. Annu Rev Genet (2012) 1.05
Combinatorial binding in human and mouse embryonic stem cells identifies conserved enhancers active in early embryonic development. PLoS Comput Biol (2011) 1.05
Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples. Int J Oncol (1999) 0.96
4DGenome: a comprehensive database of chromatin interactions. Bioinformatics (2015) 0.94
Expression of plasma membrane calcium pump isoform mRNAs in breast cancer cell lines. Cell Signal (2002) 0.89
Why is melanoma so metastatic? Pigment Cell Melanoma Res (2013) 0.89
ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma. Cancer Sci (2014) 0.86
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer. Nat Commun (2015) 0.86
Cytokine-like 1 is involved in the growth and metastasis of neuroblastoma cells. Int J Oncol (2012) 0.83
Interactions of Melanoma Cells with Distal Keratinocytes Trigger Metastasis via Notch Signaling Inhibition of MITF. Mol Cell (2015) 0.81
On the evidence for ESR1 amplification in breast cancer. Nat Rev Cancer (2012) 0.79